Fig. 1From: Anti-IL-5 therapy in patients with severe eosinophilic asthma – clinical efficacy and possible criteria for treatment responseFollow-up after anti-IL-5 therapy initiation. FEV1 (forced expiratory volume in one second)Back to article page